Denna sida har översatts automatiskt och översättningens korrekthet kan inte garanteras. Vänligen se engelsk version för en källtext.

Electrical Brain Stimulation for College Students With Short-Form Video Addiction: Effects and Mechanisms

6 november 2026 uppdaterad av: Beijing Normal University

Effects and Mechanisms of High-Definition Transcranial Direct Current Stimulation (HD-tDCS) Intervention on Short-Form Video Addiction

The researchers will test whether high-definition transcranial direct current stimulation (HD-tDCS) combined with real-time short-form video cue exposure can reduce addiction severity and daily usage time in college students with problematic short-form video use. By modulating the dorsolateral prefrontal cortex, this study aims to explore whether the treatment improves executive function (such as self-control and risk decision-making) and emotional-cognitive processes (such as craving and attentional bias). Assessments will be conducted before, immediately after the 2-week intervention, and at a 4-week follow-up, using both subjective surveys and objective computer cognitive tasks. Results could pave the way for a low-cost, non-invasive, and scalable intervention strategy to address the growing public health concern of short-form video addiction among young adults.

Studieöversikt

Status

Har inte rekryterat ännu

Betingelser

Intervention / Behandling

Detaljerad beskrivning

Over the past few years, problematic short-form video use has emerged as a significant public health concern among college students, associated with impaired executive function, academic decline, and emotional distress. Neuroimaging studies suggest that excessive short-form video consumption is linked to hypoactivity in the dorsolateral prefrontal cortex (dlPFC), which disrupts the balance between cognitive control and reward-driven habits. However, evidence-based non-pharmacological interventions for short-form video addiction remain scarce.

This study builds upon the dual-pathway model of internet addiction and utilizes a high-definition tDCS (HD-tDCS) protocol with a 4x1 ring configuration targeting the right dlPFC (center anode with 4 surrounding return electrodes) to restore prefrontal control. Participants will receive 10 daily HD-tDCS sessions over 2 consecutive weeks. Crucially, to enhance the targeted therapeutic effect, participants will undergo concurrent cue exposure-watching short-form videos on their personal mobile phones for 12 minutes during each 15-minute active or sham HD-tDCS session.

This randomized, double-blind, sham-controlled trial (N=82) employs a longitudinal design with three assessment time points (baseline, post-intervention at week 2, and a 4-week follow-up). We hypothesize that active HD-tDCS will significantly reduce addiction symptoms and usage duration compared to sham. Furthermore, we propose a parallel mediation model to explore the underlying mechanisms: specifically, whether the intervention effect is mediated by improvements in executive function (response inhibition and risk decision-making) and emotional-cognitive pathways (reductions in craving and attentional bias). Results may inform the development of scalable, neuroplasticity-based interventions to mitigate digital addiction and promote mental well-being in young adults.

The sample size was determined a priori using G*Power software (version 3.1.9.7). Based on the effect size (Cohen's f = 0.35) derived from previous meta-analytic findings regarding multiple-session tDCS interventions, assuming an alpha error probability of 0.05, a statistical power of 0.80, 2 groups, and 3 repeated measurements (i.e., pre-test, post-test, and 4-week follow-up), a minimum total sample size of 82 participants is required.

Studietyp

Interventionell

Inskrivning (Beräknad)

82

Fas

  • Inte tillämpbar

Kontakter och platser

Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.

Studiekontakt

Studieorter

  • Kina
    • Beijing Municipality
      • Beijing, Beijing Municipality, Kina, 100088
        • Department of Psychology, Beijing Normal University
        • Kontakt:

Deltagandekriterier

Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.

Urvalskriterier

Åldrar som är berättigade till studier

18 år till 30 år (Vuxen)

Tar emot friska volontärer

Nej

Kön som är behöriga för studier

Allt

Beskrivning

Inclusion Criteria:

  • Age between 18 and 30 years.
  • Currently enrolled as a university student.
  • Right-handed.
  • Meets the threshold for problematic short-form video use, as assessed by the Short-form Video Addiction Scale.
  • Primary use: The participant's primary problematic internet use is short-form videos, rather than other behaviors such as online gaming.

Exclusion Criteria:

  • Diagnosed psychiatric disorders.
  • History of neurological disease or traumatic brain injury.
  • History of epilepsy or a family history of epilepsy.
  • Presence of medical implants (e.g., cardiac pacemakers, cochlear implants).
  • Currently receiving pharmacological or psychological treatment.
  • History of receiving any non-invasive brain stimulation (e.g., tDCS, TMS, or tACS) within the past year.
  • Any other contraindications to HD-tDCS (e.g., history of skin lesions/scalp conditions at the electrode sites) or severe physical diseases identified during safety screening.

Studieplan

Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.

Hur är studien utformad?

Designdetaljer

  • Primärt syfte: Behandling
  • Tilldelning: Randomiserad
  • Interventionsmodell: Parallellt uppdrag
  • Maskning: Dubbel

Vapen och interventioner

Deltagargrupp / Arm
Intervention / Behandling
Experimentell: Active HD-tDCS Group

Participants receive active high-definition transcranial direct current stimulation (HD-tDCS) using a NeuroConn stimulator. A 4x1 ring electrode configuration is applied: the center anodal (positive) electrode is placed over the right dorsolateral prefrontal cortex (F4), surrounded by four cathodal (negative) return electrodes. The stimulation is delivered at 1.5 mA for 15 minutes. Participants receive one session per day, 5 days per week, for 2 consecutive weeks.
Enhet: Active High-Definition Transcranial Direct Current Stimulation (Active HD-tDCS)

Description: Active HD-tDCS is delivered using a NeuroConn device with a 4x1 ring configuration (center anodal electrode over the right dlPFC, surrounded by 4 cathodal returns). The stimulation is delivered at 1.5 mA for 15 minutes. Participants receive 10 sessions over 2 consecutive weeks (5 days/week). Concurrently during the stimulation, participants watch short-form videos on their mobile phones for approximately 14-15 minutes (using the same platform identified at baseline). A pre-programmed active code ensures strict double-blinding.
Sham Comparator: Sham HD-tDCS Group

Participants receive sham HD-tDCS using the identical NeuroConn device, 4x1 ring electrode configuration, and procedure as the active group. The device delivers a brief current (ramped up and down over 30 seconds) at the beginning of the 15-minute session to mimic the initial skin sensation, but the current is turned off for the remainder of the session. Participants receive one session per day, 5 days per week, for 2 consecutive weeks.
Enhet: Sham High-Definition Transcranial Direct Current Stimulation (Sham HD-tDCS)

Description: Sham HD-tDCS uses the identical NeuroConn device and 4x1 ring configuration as the active group. The current is ramped up for 30 seconds and then turned off for the remainder of the 15-minute session to mimic the initial skin sensation. Participants receive 10 sessions over 2 consecutive weeks (5 days/week). Concurrently during the sham stimulation, participants watch short-form videos on their mobile phones for approximately 14-15 minutes (using the same platform identified at baseline). A pre-programmed sham code ensures strict double-blinding.

Vad mäter studien?

Primära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Change in Short-form Video Addiction Scale Score
Tidsram: Baseline (Pre-test), Week 2 (Post-test), and Follow-up at 4 weeks after the intervention

Assessed using the 25-item Short-form Video Addiction Scale, which includes two dimensions: Addictive Dependence and Negative Consequence. Each item is scored on a 7-point Likert scale (1 = strongly disagree, 7 = strongly agree). The total score ranges from 25 to 175. A higher score indicates a more severe level of short-form video addiction.
Baseline (Pre-test), Week 2 (Post-test), and Follow-up at 4 weeks after the intervention
Change in Average Daily Short-form Video Use Duration
Tidsram: Baseline (Pre-test), Week 2 (Post-test), and Follow-up at 4 weeks after the intervention

Self-reported average time (in minutes) spent watching short-form videos per day over the past week. A higher duration indicates more excessive use.
Baseline (Pre-test), Week 2 (Post-test), and Follow-up at 4 weeks after the intervention

Sekundära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Change in Executive Function Composite Score (SSRT & BART)
Tidsram: Baseline (Pre-test), Week 2 (Post-test), and Follow-up at 4 weeks after the intervention

A composite executive function score will be derived using Exploratory Factor Analysis (EFA) from two tasks: (1) Stop-Signal Reaction Time (SSRT) from the Stop-Signal Task, and (2) Adjusted Average Pumps (AAP) from the Balloon Analogue Risk Task (BART). The factor score extracted from the EFA will serve as the composite indicator, accounting for the relative weighting of each measure. Factor scores will be oriented such that higher values indicate better overall executive function.
Baseline (Pre-test), Week 2 (Post-test), and Follow-up at 4 weeks after the intervention
Change in Emotion-Cognition Composite Score (Craving, ABS, ER)
Tidsram: Baseline (Pre-test), Week 2 (Post-test), and Follow-up at 4 weeks after the intervention

A composite emotion-cognition score will be derived using Exploratory Factor Analysis (EFA) from three measures: (1) Craving Score, (2) Attentional Bias Score (ABS) from the dot-probe task, and (3) Emotion Regulation Score. The factor score extracted from the EFA will serve as the composite indicator to capture the shared variance among these measures. Factor scores will be oriented such that higher values indicate more favorable emotional-cognitive outcomes.
Baseline (Pre-test), Week 2 (Post-test), and Follow-up at 4 weeks after the intervention

Samarbetspartners och utredare

Det är här du hittar personer och organisationer som är involverade i denna studie.

Sponsor

Beijing Normal University

Samarbetspartners

National Natural Science Foundation of China

Publikationer och användbara länkar

Den som ansvarar för att lägga in information om studien tillhandahåller frivilligt dessa publikationer. Dessa kan handla om allt som har med studien att göra.

Användbara länkar

Studieavstämningsdatum

Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.

Studera stora datum

Studiestart (Beräknad)

15 november 2026

Primärt slutförande (Beräknad)

31 maj 2027

Avslutad studie (Beräknad)

30 juni 2027

Studieregistreringsdatum

Först inskickad

6 november 2026

Först inskickad som uppfyllde QC-kriterierna

6 november 2026

Första postat (Faktisk)

12 november 2026

Uppdateringar av studier

Senaste uppdatering publicerad (Faktisk)

12 november 2026

Senaste inskickade uppdateringen som uppfyllde QC-kriterierna

6 november 2026

Senast verifierad

1 oktober 2026

Mer information

Termer relaterade till denna studie

Nyckelord

Ytterligare relevanta MeSH-villkor

Andra studie-ID-nummer

  • BNU202610120439

Plan för individuella deltagardata (IPD)

Planerar du att dela individuella deltagardata (IPD)?

OBESLUTSAM

Läkemedels- och apparatinformation, studiedokument

Studerar en amerikansk FDA-reglerad läkemedelsprodukt

Nej

Studerar en amerikansk FDA-reglerad produktprodukt

Nej

Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .

Prenumerera